Shortly after the injury, CAYKQ was administered intravenously to the animals. This peptide automatically accumulated in the part of the brain where the injury occurred. This happened because, after an injury, a specific type of protein starts being produced in excess in the brain, and CAYKQ is attracted to that protein. Where this peptide accumulated, swelling reduced, brain cell death decreased, and overall brain damage was mitigated.